The value of sentinel node biopsy in patients with primary cutaneous melanoma

Dermatologic Surgery

Volumn 34, Issue 4, 2008, Pages 550-555

  Thompson, John F ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

CANCER ADJUVANT THERAPY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MELANOMA; MORBIDITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

HUMANS; MELANOMA; MULTICENTER STUDIES AS TOPIC; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 41149083624     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.34100.x     Document Type: Review

References (41)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992 127 : 392 9.
2. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994 220 : 759 67.
3. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995 5 : 255 60.
4. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006 355 : 1307 17.
5. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005 242 : 302 11, discussion 311-3.
6. McMasters KM. The Sunbelt Melanoma Trial. Ann Surg Oncol 2001 8 (9 Suppl) : 41S 3S.
7. McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol 2004 86 : 212 23.
8. Chao C, Martin RC 2nd., Ross MI, et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004 11 : 259 64.
9. Pharis DB, Zitelli JA. The management of regional lymph nodes in cancer. Br J Dermatol 2003 149 : 919 25.
10. White RR, Stanley WE, Johnson JL, et al. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis. Ann Surg 2002 235 : 879 87.
11. Young SE, Martinez SR, Faries MB, et al. Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes? Cancer J 2006 12 : 207 11.
12. Gershenwald JE, Ross MI. Is sentinel-node biopsy superior to nodal observation in melanoma? Nat Clin Pract Oncol 2007 4 : 278 9.
13. Scheri RP, Essner R, Turner RR, et al. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol 2007 14 : 2861 6.
14. Morton DL, Cochran AJ, Thompson JF. Sentinel-node biopsy in melanoma - authors reply. N Engl J Med 2007 356 : 419 20.
15. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999 86 : 617 27.
16. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol 2003 27 : 1197 202.
17. Morton DL, Hoon DS, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003 238 : 538 49, discussion 549-50.
18. Takeuchi H, Morton DL, Kuo C, et al. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol 2004 22 : 2671 80.
19. Romanini A, Manca G, Pellegrino D, et al. Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome. Ann Oncol 2005 16 : 1832 40.
20. Mocellin S, Hoon DS, Pilati P, et al. Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. J Clin Oncol 2007 25 : 1588 95.
21. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001 19 : 3635 48.
22. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999 17 : 976 83.
23. McMasters KM, Sondak VK, Lotze MT, et al. Recent advances in melanoma staging and therapy. Ann Surg Oncol 1999 6 : 467 75.
24. Balch CM, Buzaid AC, Atkins MB, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 2000 88 : 1484 91.
25. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001 19 : 3622 34.
26. Ferrone CR, Panageas KS, Busam K, et al. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol 2002 9 : 637 45.
27. Zettersten E, Shaikh L, Ramirez R, et al. Prognostic factors in primary cutaneous melanoma. Surg Clin North Am 2003 83 : 61 75.
28. Roka F, Kittler H, Cauzig P, et al. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. Br J Cancer 2005 92 : 662 7.
29. Topar G, Eisendle K, Zelger B, Fritsch P. Sentinel lymph node status in melanoma: a valuable prognostic factor? Br J Dermatol 2006 154 : 1080 7.
30. Johnson JR, Williams G, Pazdur R. End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol 2003 21 : 1404 11.
31. Gershenwald JE, Berman RS, Porter G, et al. Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol 2000 7 : 226 31.
32. Balch CM, Cascinelli N. Sentinel-node biopsy in melanoma. N Engl J Med 2006 355 : 1370 1.
33. Balch CM, Cascinelli N. Sentinel-node biopsy in melanoma - the editorialists reply. N Engl J Med 2007 356 : 420 1.
34. Morton DL, Cochran AJ, Thompson JF. Authors' response to a letter to the editor re: sentinel node biopsy for early-stage melanoma. Ann Surg 2007 245 : 828 9.
35. Sabel MS, Griffith K, Sondak VK, et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 2005 201 : 37 47.
36. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001 91 : 2110 21.
37. Cochran AJ, Wen DR, Huang RR, et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004 17 : 747 55.
38. Scolyer RA, Li LX, McCarthy SW, et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 2004 122 : 532 9.
39. Dewar DJ, Newell B, Green MA, et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004 22 : 3345 9.
40. Lean CL, Bourne R, Thompson JF, et al. Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens. Melanoma Res 2003 13 : 259 61.
41. Bourne RM, Stanwell P, Stretch JR, et al. In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. Eur J Radiol 2005 53 : 506 13.